Skip to main content

Table 3 Perioperative blood routine examination and transfusion data for all patients

From: The role of acute normovolemic hemodilution in reducing allogeneic blood transfusion in glioblastoma surgery: a case–control study

 

ANH (n = 25)

Non-ANH (n = 35)

P value

Hemoglobin (g/dL)

 Preoperative

13.9 ± 1.7

13.9 ± 1.4

0.967

 Intraoperative

12.9 ± 2.1

13.6 ± 1.7

0.201

 Postoperative day 1

12.7 ± 1.9

11.6 ± 1.6

0.021

 Postoperative day 3

12.0 ± 1.6

10.7 ± 1.4

0.002

Platelet count (K/μL)

 Preoperative

248.4 ± 70.7

221.5 ± 57.0

0.107

 Postoperative day 1

211.6 ± 58.4

193.2 ± 56.4

0.225

 Postoperative day 3

202.8 ± 63.1

180.0 ± 33.7

0.108

Allogeneic RBC transfusion

 Patients, %

3 (12%)

12 (34.3%)

0.049

 Total volume (U)

6

37

 

 Unit per patient with transfusion (U)

3.33 ± 1.15

3.08 ± 1.00

0.711

 Unit per total of patients (U)

0.40 ± 1.15

1.06 ± 1.59

0.069

FFP transfusion

 Patients, %

2 (8%)

11 (31.4%)

0.030

 Total volume (mL)

800

4050

 

 Volume per patient with transfusion (mL)

400.00 ± 141.42

368.18 ± 95.58

0.689

 Volume per total of patients (mL)

32.00 ± 114.46

115.71 ± 181.00

0.033

  1. Data are mean ± SD. P values were calculated by Student’s t test, or Mann–Whitney U test, as appropriate. ANH acute normovolemic hemodilution, RBC red blood cell, FFP fresh frozen plasma